Showing results (51-60 of 185) with videos related to
Sort By:
Pageof 19
Tumori|October 31, 1991
Evaluation of the effect of medroxyprogesterone acetate on bone marrow progenitor cellsP Pedrazzoli, G Bacciocchi, G A Da Prada, et al.Journal of Neurosurgery|November 1, 1990
Characteristics and biological role of steroid hormone receptors in neuroepithelial tumorsP Paoletti, G Butti, C Zibera, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetic evaluation of two different formulations of megestrol acetate in patients with advanced malignanciesC M Camaggi, E Strocchi, A Martoni, et al.Bone Marrow Transplantation|April 1, 1994
Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplantsF Locatelli, M Zecca, P Pedrazzoli, et al.Cytometry|October 9, 2001
Circulating CD33+ large mononuclear cells contain three distinct populations with phenotype of putative antigen-presenting cells including myeloid dendritic cells and CD14+ monocytes with their CD16+ subsetF F Fagnoni, B Oliviero, C Zibera, et al.Cancer Chemotherapy and Pharmacology|January 1, 1982
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncologyV Tamassia, A Battaglia, F Ganzina, et al.Journal of Neuro-Oncology|June 1, 1991
A study on the biological behavior of human brain tumors. Part II: Steroid receptors and arachidonic acid metabolismG Butti, P Gaetani, C Chiabrando, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative GroupG Bonadonna, M Zambetti, C Bumma, et al.Journal of Chemotherapy (Florence, Italy)|June 12, 2003
Randomized, controlled, multicenter phase III trial of standard-dose fluorouracil-epirubicin-cyclophosphamide (FEC), compared with time-intensive FEC (FEC-G) and mitoxantrone-methotrexate-mitomycin C (MMM-G) in metastatic breast carcinomaA M Capotorto, L Pavesi, P Pedrazzoli, et al.Blood|November 24, 1999
Coexistence of two functioning T-cell repertoires in healthy ex-thalassemics bearing a persistent mixed chimerism years after bone marrow transplantationM Battaglia, M Andreani, M Manna, et al.Pageof 19